Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Conivaptan effects on exercise tolerance in patients with chronic heart failure

Sep. 26, 2003

Beneficial effects of eplerenone in AMI patients with low LVEF

Sep. 26, 2003

Avant to conduct phase II trial of TP-10 in women

Sep. 26, 2003

Tolvaptan preserves renal function in patients with congestive heart failure

Sep. 25, 2003

European Commission approval granted for Ventavis

Sep. 23, 2003

PhotoPoint PDT may provide benefit in coronary and peripheral atherosclerotic disease

Sep. 23, 2003

ALT-711 to be further developed based on encouraging safety and efficacy data

Sep. 23, 2003

Kv1.5 potassium channel blockers presented by BMS and ICAgen

Sep. 22, 2003

Atorvastatin improves walking distance in patients with peripheral artery disease

Sep. 22, 2003

Potential role for acetylcholinesterase inhibitors in neurogenic orthostatic hypotension

Sep. 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...